Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License ...

Shorla Oncology (?Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, ...